EGFR and infection: Blockade of the receptor using an anti-EGFR antibody to inhibit ligand binding (ICR62)[29] or using tyrosine kinase inhibitors to inactivate the signalling capability of the receptor (Iressa/Gefitinib or Tyrphostin-AG99) also had no effect on cell survival following infection with reovirus (P > 0.1 for all analyses).